Please login to the form below

Not currently logged in
Email:
Password:

Aesica creates commercial MD role

Appoints Catalent’s Ian Muir to new position

Aesica has named Ian Muir as the company's first commercial managing director, effective February 24.

The contract development and manufacturing (CDMO) firm Aesica said the creation of the role reflects the company's decision to focus on 'core commercial activities'.

Muir's responsibilities will cover manufacture of active pharmaceutical ingredients, formulation development and formulated products, while he will also lead the expansion of the business into new markets, such as China and Japan.

He joins from the CDMO Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms.

Muir's previous experience also includes commercial responsibilities in the US, Australia and Japan.

Aesica's CEO Robert Hardy said: “Ian brings strong commercial business knowledge and has proven experience of delivering growth and will play a pivotal role in driving further business growth for Aesica across API, formulation development and formulated products.”

5th February 2014

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...